s6y

S-3 Registration statement for specified transactions by certain issuers

Filed
Accession number
0001213900-26-092612

Documents

  1. REGISTRATION STATEMENT S-3
  2. AMENDMENT NO. 1 TO THE SALES AGREEMENT BETWEEN ORUKA THERAPEUTICS, INC. AND TD SECURITIES (USA) LLC, DATED AUGUST 21, 2026 EX-1.3
  3. OPINION OF DAVIS POLK & WARDWELL LLP RELATING TO THE BASE PROSPECTUS EX-5.1
  4. OPINION OF DAVIS POLK & WARDWELL LLP RELATING TO THE SALES AGREEMENT PROSPECTUS EX-5.2
  5. CONSENT OF PRICEWATERHOUSECOOPERS LLP, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM EX-23.1
  6. FILING FEE TABLE EX-FILING FEES

On sec.gov